IXC Ann: Invex to close IIH Evolve Phase III Clinical Trial - 21st Aug 2023, 9:23am

annb0t

annb0t

Top 20
IXC Ann: Invex to close IIH Evolve Phase III Clinical Trial
Price Sensitive: Y
Date: 21st Aug 2023, 9:23am

>>> Read announcement: Google: IXC Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
IXC Ann: Invex issued US patent for Traumatic Brain Injury - 23rd Aug 2023, 11:58am
Replies
0
Views
60
annb0t
annb0t
annb0t
IXC Ann: Invex Granted European Orphan Drug Designation for TBI - 23rd Jun 2023, 8:18am
Replies
0
Views
103
annb0t
annb0t
annb0t
IXC Ann: Invex Receives Regulatory Approval for IIH EVOLVE in France - 21st Apr 2023, 8:17am
Replies
0
Views
113
annb0t
annb0t
annb0t
IXC Ann: Publication of Invex IIH Phase II Pressure Trial Results - 14th Mar 2023, 8:11am
Replies
0
Views
95
annb0t
annb0t
annb0t
IXC Ann: Invex Receives Approval for Paediatric Plan from the EMA - 14th Dec 2022, 9:05am
Replies
0
Views
215
annb0t
annb0t
Top Bottom